Literature DB >> 29779596

Muscular Dystrophies.

John C Carter1, Daniel W Sheehan2, Andre Prochoroff3, David J Birnkrant4.   

Abstract

Muscular dystrophies represent a complex, varied, and important subset of neuromuscular disorders likely to require the care of a pulmonologist. The spectrum of conditions encapsulated by this subset ranges from severe and fatal congenital muscular dystrophies with onset in infancy to mild forms of limb and girdle weakness with onset in adulthood and minimal respiratory compromise. The list and classification of muscular dystrophies are undergoing near-constant revision, based largely on new insights from genetics and molecular medicine. The authors present an overview of the muscular dystrophies, including their basic features, common clinical phenotypes, and important facets of management.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Duchenne muscular dystrophy; Facioscapulohumeral muscular dystrophy; Limb girdle muscular dystrophy; Muscular dystrophy; Respiratory failure

Mesh:

Year:  2018        PMID: 29779596     DOI: 10.1016/j.ccm.2018.01.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  13 in total

1.  Post-translational Modification in Muscular Dystrophies.

Authors:  Martina Sandonà; Valentina Saccone
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy.

Authors:  Paulina Podkalicka; Olga Mucha; Katarzyna Kaziród; Iwona Bronisz-Budzyńska; Sophie Ostrowska-Paton; Mateusz Tomczyk; Kalina Andrysiak; Jacek Stępniewski; Józef Dulak; Agnieszka Łoboda
Journal:  Biomedicines       Date:  2021-04-27

3.  CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report.

Authors:  Liting Chen; Bin Xu; Wanying Liu; Di Wang; Jinhuan Xu; Xia Mao; Min Xiao; Jianfeng Zhou; Yi Xiao
Journal:  Onco Targets Ther       Date:  2022-04-08       Impact factor: 4.147

4.  Characterization of individuals with selected muscular dystrophies from the expanded pilot of the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) in the United States.

Authors:  Bailey Wallace; K Tiffany Smith; Shiny Thomas; Kristin M Conway; Christina Westfield; Jennifer G Andrews; Richard O Weinert; Thuy Quynh N Do; Natalie Street
Journal:  Birth Defects Res       Date:  2020-07-24       Impact factor: 2.661

5.  Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.

Authors:  Peng Zhang; Jian He; Fei Wang; Jing Gong; Lu Wang; Qian Wu; Wenjiong Li; Hongju Liu; Jing Wang; Kunshan Zhang; Mao Li; Xusheng Huang; Chuanqiang Pu; Ying Li; Fengjie Jiang; Fudi Wang; Junxia Min; Xiaoping Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-18       Impact factor: 12.910

6.  Molecular Genetics Analysis of 70 Chinese Families With Muscular Dystrophy Using Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing.

Authors:  Dong Wang; Min Gao; Kaihui Zhang; Ruifeng Jin; Yuqiang Lv; Yong Liu; Jian Ma; Ya Wan; Zhongtao Gai; Yi Liu
Journal:  Front Pharmacol       Date:  2019-07-25       Impact factor: 5.810

Review 7.  A Journey with LGMD: From Protein Abnormalities to Patient Impact.

Authors:  Dimitra G Georganopoulou; Vasilis G Moisiadis; Firhan A Malik; Ali Mohajer; Tanya M Dashevsky; Shirley T Wuu; Chih-Kao Hu
Journal:  Protein J       Date:  2021-06-10       Impact factor: 2.371

8.  The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice.

Authors:  Yasunari Matsuzaka; Jun Tanihata; Yoshiko Ooshima; Daisuke Yamada; Masayuki Sekiguchi; Shouta Miyatake; Yoshitsugu Aoki; Mika Terumitsu; Ryu Yashiro; Hirofumi Komaki; Akihiko Ishiyama; Yasushi Oya; Yukiko U Inoue; Takayoshi Inoue; Shin'ichi Takeda; Kazuo Hashido
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

9.  Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.

Authors:  Agnieszka Łoboda; Józef Dulak
Journal:  Pharmacol Rep       Date:  2020-07-20       Impact factor: 3.024

Review 10.  Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences.

Authors:  Thuy-Hang Nguyen; Stephanie Conotte; Alexandra Belayew; Anne-Emilie Declèves; Alexandre Legrand; Alexandra Tassin
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.